Veterinary chewable excipients market seen growing 7.1% annually to 2030

The veterinary chewable base excipients market is projected to rise from $1.63 billion in 2026 to $2.15 billion by 2030, according to The Business Research Company. Growth is being driven by pet ownership, chronic animal disease, and demand for easier-to-administer medications, with North America leading and Asia-Pacific expected to grow fastest.

Why it matters: - Veterinary chewable base excipients help make animal medicines more palatable, which can improve dosing compliance and treatment effectiveness. - The market’s growth reflects broader spending on pet health, companion-animal care, and more user-friendly drug formats. - The shift also supports demand for advanced drug delivery systems, including sustainable and precision-formulation options.

What happened: - The Business Research Company said the global veterinary chewable base excipients market will grow at a 7.1% CAGR through the forecast period. - The market is projected to increase from $1.53 billion in 2025 to $1.63 billion in 2026. - The market is expected to reach $2.15 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, and the Middle East and Africa.

The details: - Veterinary chewable base excipients are inactive ingredients used in chewable animal medications to improve taste, texture, and palatability. - The excipients also give chewable medications structure and make them easier for animals to consume. - The report links 2025-2026 market growth to poor palatability, low medication adherence, reliance on tablets and injectables, limited species-specific flavored medications, and continued use of sugar and gelatin-based excipients. - The company said future growth will be driven by AI-driven formulation design, palatability prediction tools, personalized veterinary medicine, biodegradable excipients, advanced animal drug delivery systems, and precision dosing. - The report highlights AI-enhanced palatability optimization, smart manufacturing, cloud-based formulation tracking, improved flavor masking, and eco-friendly excipient development as major trends. - One growth driver is pet ownership, with the American Pet Products Association reporting 94 million U.S. households owned at least one pet in March 2025, up from 82 million in 2023. - Another driver is the rise in chronic and lifestyle diseases in animals, including obesity, diabetes, and osteoarthritis. - Portland Vets Limited reported in October 2024 that 45% of animals under its care were overweight or obese, including 46% of dogs and 43% of cats. - Veterinary healthcare infrastructure is also expanding as more clinics, hospitals, specialists, and support services come online. - The American Veterinary Medical Association reported that U.S. veterinarians increased from 124,069 in 2022 to 127,131 in 2023. - The report says its 2026 editions now include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Between the lines: - The market is moving from basic flavor-and-texture excipients toward formulation systems tied to data, automation, and sustainability. - That suggests veterinary medicine is adopting the same compliance and personalization pressures already common in human pharmaceuticals. - The strongest demand signal comes from owners treating pets more like family members, which raises willingness to pay for easier medication formats.

What's next: - The report expects sustained growth through 2030 as formulation technology improves and animal health spending broadens. - Watch for more AI-assisted excipient design, automated manufacturing, and sustainable ingredient adoption in veterinary drug development. - Regional momentum may continue to shift toward Asia-Pacific as veterinary care access and pet ownership expand.

The bottom line: - Veterinary chewable base excipients are becoming a bigger part of animal health as the industry pushes for better compliance, better taste, and more advanced medication delivery.